CD47 and neoplasm: Another study showed that bioinspired hybrid nanoparticles called miR-497/TP-HENPs, formed by CD47-expressed exosomes from SKOV3-CDDP cells and cRGD-modified liposomes, increased drug delivery to target tumor sites by evading MPS clearance.